DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Ensor CR, Yousem SA, Marrari M. et al.
Proteasome inhibitor carfilzomib-based therapy for antibody-mediated rejection of the pulmonary allograft: use and short-term findings.
Am J Transplant 2017;
17 (05) 1380-1388
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.